Bilibili Inc
NASDAQ:BILI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.94
29.66
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bilibili Inc
Wall Street
Price Targets
BILI Price Targets Summary
Bilibili Inc
According to Wall Street analysts, the average 1-year price target for
BILI
is 22.7 USD
with a low forecast of 12.12 USD and a high forecast of 30.98 USD.
BILI Last Price Targets
Bilibili Inc
The latest public price target was made on Sep 25, 2024 by
Lincoln Kong
from
Goldman Sachs
,
who expects
BILI
stock to
rise by 15%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Lincoln Kong
Goldman Sachs
|
22.6
USD
Upside 15% |
2 months ago
Sep 25, 2024
|
Goldman Sachs Upgrades Bilibili (BILI) to Buy
StreetInsider
|
Jiong Shao
Barclays
|
19
USD
Downside 3% |
3 months ago
Aug 23, 2024
|
Bilibili upgraded to Overweight from Equal Weight at Barclays
TheFly
|
|
John Choi
Daiwa
|
16
USD
Downside 18% |
4 months ago
Aug 22, 2024
|
Bilibili upgraded to Outperform from Hold at Daiwa
TheFly
|
|
Jialong Shi
Nomura
|
18
USD
Downside 8% |
4 months ago
Aug 22, 2024
|
Nomura/Instinet Upgrades Bilibili (BILI) to Buy
StreetInsider
|
Brian Gong
Citigroup
|
18
USD
Downside 8% |
4 months ago
Aug 5, 2024
|
Bilibili (BILI) PT Raised to $18 at Citi
StreetInsider
|
Alex Poon
Morgan Stanley
|
14
USD
Downside 29% |
6 months ago
Jun 13, 2024
|
Morgan Stanley Reiterates Equalweight Rating on Bilibili (BILI)
StreetInsider
|
Felix Liu
UBS
|
18
USD
Downside 8% |
6 months ago
May 31, 2024
|
UBS Upgrades Bilibili (BILI) to Buy
StreetInsider
|
|
Jiong Shao
Barclays
|
14
USD
Downside 29% |
6 months ago
May 24, 2024
|
Barclays Upgrades Bilibili (BILI) to Equalweight
StreetInsider
|
|
Elinor Leung
CLSA
|
16.8
USD
Downside 14% |
7 months ago
May 10, 2024
|
Bilibili upgraded to Buy from Outperform at CLSA
TheFly
|
Wei Fang
Mizuho Securities
|
17
USD
Downside 13% |
7 months ago
May 10, 2024
|
Bilibili price target raised to $17 from $15 at Mizuho
TheFly
|
|
Wei Fang
Mizuho Securities
|
18
USD
Downside 8% |
1 year ago
Nov 6, 2023
|
Bilibili To Double Total Addressable Market To $200B With New Product Launches: Analyst
Benzinga
|
|
Brian Gong
Citigroup
|
28
USD
Upside 43% |
1 year ago
Mar 3, 2023
|
Bilibili Likely To Gain From New Game Launches, Auto, 3C And Recovery In Performance Based Ads, Analysts Say
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BILI's stock price target?
Price Target
22.7
USD
According to Wall Street analysts, the average 1-year price target for
BILI
is 22.7 USD
with a low forecast of 12.12 USD and a high forecast of 30.98 USD.
What is Bilibili Inc's Revenue forecast?
Projected CAGR
15%
For the last 7 years the
compound annual growth rate for
Bilibili Inc's revenue is
71%.
The projected
CAGR
for the next 4 years is
15%.
You don't have any saved screeners yet
